In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Biotechnology
In a filing with the US Securities and Exchange Commission (SEC), bluebird bio has announced the departure of its chief medical officer, David Davidson. 17 March 2021
Biotechnology
Belgium’s AgomAb Therapeutics says it has closed a $74 million Series B financing round led by Redmile Group, which will further advance its lead compound AGMB-101. 10 March 2021
Generics
Experienced life sciences leader Bryan Chu Young Kim will strengthen the global leadership team at German drugmaker Stada Arzneimittel as head of global specialties, effective April 1, 2021. 5 March 2021
Generics
Kartesia, a European specialist provider of capital solutions for small and mid-sized companies, says it has completed a 12 million-euro ($14.6 million) capital increase in ADL Biopharma has become the sole shareholder of the Spanish biopharmaceutical company, which focuses on the development and production of active pharmaceutical ingredients (APIs) and specialty ingredients. 1 March 2021
Pharmaceutical
Japan’s Daiichi Sankyo today announced Ken Takeshita will be named the new global head of Research & Development as of April 1, 2021. 22 February 2021
Biotechnology
Parisian biotech Advicenne has provided a business update, highlighting a recent positive scientific opinion for lead medicine ADV7103 (potassium citrate/potassium hydrogen carbonate) in Europe. 19 February 2021
Biotechnology
A new pharmaceutical R&D model was created today, with the merger of 10 privately-held biotech companies with highly validated programs led by industry leading teams to operate under the Centessa umbrella. 17 February 2021
Pharmaceutical
Eli Lilly saw its shares drop as much as 2.5% yesterday, after it was revealed that its chief financial officer, Josh Smiley, was leaving the company because of ‘inappropriate’ conduct. 10 February 2021
Pharmaceutical
Spanish skincare specialist Almirall has appointed Gianfranco Nazzi as chief executive and executive director of the board of directors effective May 1, 2021. 8 February 2021
Biotechnology
Japanese drugmaker Astellas Pharma has boosted its senior management team, creating two new positions which will report directly to chief executive Kenji Yasukawa. 5 February 2021
Pharmaceutical
German pharma, science and technology company Merck KGAA today announced that Rehan Verjee has made the decision to leave his position as president of its EMD Serono unit and global head of innovative medicine franchises, to pursue an opportunity outside of Merck that will soon be announced. 4 February 2021
Pharmaceutical
Kenneth Frazier, one of the biggest names in pharma, is to retire from his position of chief executive of Merck & Co (NYSE: MRK) after a decade in the role. 4 February 2021
Biotechnology
French biopharma firm Tollys has appointed Philippe Goupit as chairman of the board of directors. 1 February 2021
Biotechnology
Vivek Ramaswamy, chief executive of Roivant Sciences, is to move aside from his role as chief executive to become executive chairman. 25 January 2021
Biotechnology
Francesco Marincola will join Kite as senior vice president and global head of cell therapy research, effective February 1, said the biotech firm. 19 January 2021
Biosimilars
The International Generic and Biosimilar Medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, has announced that Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance (IPA), is taking over the position of IGBA chairman for 2021 from Hanan Sboul, secretary general of the Jordanian Association of Pharmaceutical Manufacturers. 18 January 2021
Biotechnology
Natural killer (NK) cell therapy company ONK Therapeutics has appointed Mary Reilly as chief operating officer. 18 January 2021
Biotechnology
US biotech Novavax today announced the appointment of Henrietta Ukwu to the position of senior vice president, chief regulatory and quality officer. 15 January 2021
Biotechnology
AskBio says that Katherine High has joined the company in the newly-formed role of president, therapeutics, and will also serve on its board of directors. 13 January 2021
Biotechnology
USA-based biotech firm bluebird bio has announced a plan to split into two separate companies, with one focusing on severe genetic disease and another on oncology. 12 January 2021
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze